107 related articles for article (PubMed ID: 18313615)
1. Calcium channel blocker and adenosine triphosphate terminate bidirectional ventricular tachycardia in a patient with Andersen-Tawil syndrome.
Sumitomo N; Shimizu W; Taniguchi K; Hiraoka M
Heart Rhythm; 2008 Mar; 5(3):498-9. PubMed ID: 18313615
[No Abstract] [Full Text] [Related]
2. Flecainide suppresses bidirectional ventricular tachycardia and reverses tachycardia-induced cardiomyopathy in Andersen-Tawil syndrome.
Pellizzón OA; Kalaizich L; Ptácek LJ; Tristani-Firouzi M; Gonzalez MD
J Cardiovasc Electrophysiol; 2008 Jan; 19(1):95-7. PubMed ID: 17655675
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of flecainide in bidirectional ventricular tachycardia and tachycardia-induced cardiomyopathy with Andersen-Tawil syndrome.
Ünal Yüksekgönül A; Azak E; Akalın A; Ertuğrul İ; Kılıç E; Utine GE; Karagöz T
Eur J Med Genet; 2022 Jun; 65(6):104499. PubMed ID: 35429663
[TBL] [Abstract][Full Text] [Related]
4. Oral verapamil effectively suppressed complex ventricular arrhythmias and unmasked U waves in a patient with Andersen-Tawil syndrome.
Erdogan O; Aksoy A; Turgut N; Durusoy E; Samsa M; Altun A
J Electrocardiol; 2008; 41(4):325-8. PubMed ID: 18353348
[TBL] [Abstract][Full Text] [Related]
5. Can flecainide totally eliminate bidirectional ventricular tachycardia in pediatric patients with Andersen-Tawil syndrome?
Ergül Y; Özgür S; Onan SH; Tuzcu V
Turk Kardiyol Dern Ars; 2018 Dec; 46(8):718-722. PubMed ID: 30516532
[TBL] [Abstract][Full Text] [Related]
6. Adenosine triphosphate terminates bidirectional ventricular tachycardia in a patient with catecholaminergic polymorphic ventricular tachycardia.
Sumitomo N; Sakurada H; Mugishima H; Hiraoka M
Heart Rhythm; 2008 Mar; 5(3):496-7. PubMed ID: 18313614
[No Abstract] [Full Text] [Related]
7. Flecainide for recurrent malignant ventricular arrhythmias in two siblings with Andersen-Tawil syndrome.
Bökenkamp R; Wilde AA; Schalij MJ; Blom NA
Heart Rhythm; 2007 Apr; 4(4):508-11. PubMed ID: 17399642
[No Abstract] [Full Text] [Related]
8. Successful treatment of arrhythmia with β-blocker and flecainide combination in pregnant patients with Andersen-Tawil syndrome: A case report and literature review.
Rujirachun P; Junyavoraluk A; Pithukpakorn M; Suktitipat B; Winijkul A
Ann Noninvasive Electrocardiol; 2021 May; 26(3):e12798. PubMed ID: 32959505
[TBL] [Abstract][Full Text] [Related]
9. Response to flecainide test in Andersen-Tawil syndrome with incessant ventricular tachycardia.
Fernández M; Marín MDR; Fernández-Armenta J; Mora-López F; Fernández Rivero R; Berruezo A; Cano Calabria L; Vázquez García R
Pacing Clin Electrophysiol; 2018 Apr; 41(4):429-432. PubMed ID: 29023786
[No Abstract] [Full Text] [Related]
10. Alternans of diastolic intracellular calcium elevation as the mechanism of bidirectional ventricular tachycardia in a rabbit model of Andersen-Tawil syndrome.
Maruyama M; Lin SF; Chen PS
Heart Rhythm; 2012 Apr; 9(4):626-7. PubMed ID: 21167318
[No Abstract] [Full Text] [Related]
11. Combined inhibition of Na⁺ and Ca²⁺ channels: a novel paradigm for the treatment of incessant ventricular arrhythmias in Andersen-Tawil syndrome.
Janson CM; Poelzing S; Shah MJ
Heart Rhythm; 2014 Feb; 11(2):318-20. PubMed ID: 24211314
[No Abstract] [Full Text] [Related]
12. Rarity and phenotypic heterogeneity provide challenges in the diagnosis of Andersen-Tawil syndrome: Two cases presenting with ECGs mimicking catecholaminergic polymorphic ventricular tachycardia (CPVT).
Tully I; Atherton J; Hunt L; Ingles J; Semsarian C; McGaughran J
Int J Cardiol; 2015 Dec; 201():473-5. PubMed ID: 26322597
[No Abstract] [Full Text] [Related]
13. The effects of adenosine on idiopathic ventricular tachycardia.
Ng KS; Wen MS; Yeh SJ; Lin FC; Wu D
Am J Cardiol; 1994 Jul; 74(2):195-7. PubMed ID: 8023793
[No Abstract] [Full Text] [Related]
14. [Andersen-Tawil syndrome. Efficacy of class IC drugs].
Makarov LM; Komoliatova VN; Kolosov VO; Fedina NN; Solokhin IuA
Kardiologiia; 2013; 53(1):91-6. PubMed ID: 23548357
[TBL] [Abstract][Full Text] [Related]
15. Effect of flecainide on T-wave alternans in Andersen-Tawil syndrome.
Hayashi H; Kawaguchi T; Horie M
Ann Noninvasive Electrocardiol; 2014 Jul; 19(4):383-6. PubMed ID: 25040481
[No Abstract] [Full Text] [Related]
16. Bidirectional Ventricular Tachycardia in a Young Female: A Case of Andersen-Tawil Syndrome.
Ransom JL; Wong KC; Kircher J; Usry C; Larson C
Mil Med; 2023 Jan; 188(1-2):e412-e416. PubMed ID: 33605413
[TBL] [Abstract][Full Text] [Related]
17. Bidirectional Ventricular Tachycardia: Challenges and Solutions.
Almarzuqi A; Kimber S; Quadros K; Senaratne J
Vasc Health Risk Manag; 2022; 18():397-406. PubMed ID: 35698640
[TBL] [Abstract][Full Text] [Related]
18. A case of Andersen-Tawil syndrome presenting periodic paralysis exacerbated by acetazolamide.
Nagamine S; Sakoda S; Koide R; Kawata A; Yuan J; Takashima H; Nakano I
J Neurol Sci; 2014 Dec; 347(1-2):385-6. PubMed ID: 25284084
[No Abstract] [Full Text] [Related]
19. Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation.
Delannoy E; Sacher F; Maury P; Mabo P; Mansourati J; Magnin I; Camous JP; Tournant G; Rendu E; Kyndt F; Haïssaguerre M; Bézieau S; Guyomarch B; Le Marec H; Fressart V; Denjoy I; Probst V
Europace; 2013 Dec; 15(12):1805-11. PubMed ID: 23867365
[TBL] [Abstract][Full Text] [Related]
20. Andersen-Tawil syndrome associated with aborted sudden cardiac death: atrial pacing was effective for ventricular arrhythmias.
Kuramoto Y; Furukawa Y; Yamada T; Okuyama Y; Fukunami M
Am J Med Sci; 2012 Sep; 344(3):248-50. PubMed ID: 22739561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
